Stock Taper
SCREENER COMPARE ANY 2 STOCKS
PLRZ
POLYRIZON LTD.
NASDAQ
$10.30
▼ DOWN 1.81% (-0.19)

KEY STATISTICS

Market Cap$11.54 M
52w High$18.20
52w Low$2.88
Dividend Yield—
Frequency—
P/E-5.26
Volume20.94K
Shares Out.1.12M

COMPANY

LEADERSHIP

Tomer Izraeli
CHIEF EXECUTIVE
Tomer Izraeli

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 29, 2024
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
6

SPLIT RECORD

DATETYPERATIO
2025-11-28Reverse1:6
2025-05-27Reverse1:250

PRICE

$10.30 ▼ DOWN 1.81% (−$0.19)
OVERLAYS
$10.35$10.50$10.65$10.809:53 AM10:53 AM11:53 AM12:53 PM1:52 PM2:52 PM3:52 PM10.30

About Polyrizon Ltd.

https://www.polyrizon-biotech.com ↗

Polyrizon Ltd. is an Israeli biotech company developing hydrogel nasal sprays that block viruses and allergens, including PL-14 for allergies, PL-15 for COVID-19, and PL-16 for influenza.

INDUSTRY

Biotechnology

A PRODUCT POLYRIZON LTD. IS KNOWN FOR

NASARIX™ (formerly PL-14 Allergy Blocker)
NASARIX™ (formerly PL-14 Allergy Blocker)

NASARIX™ is an intranasal hydrogel spray that creates a barrier in the nasal cavity to block airborne allergens, with positive preclinical results and branding positioning it as a key product in Polyrizon's pipeline.

COMPETITORS

COMPETITOR
HLN COMPARE
KVUE COMPARE
OGN COMPARE
SPRY COMPARE

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Izraeli Tomer
Sale · 500 shares
2026-03-31
★
DIRECTOR
Carmel Liron
Sale · 942 shares
2026-03-31
★
DIRECTOR
Adler Oz
Sale · 3.3K shares
2026-03-31
★
DIRECTOR
Carmel Liron
Sale · 100 shares
2026-03-30

SECTORS PEERS

PEERPRICE
XTLB$2.78COMPARE
CYCN$3.89COMPARE
KTTA$0.54COMPARE
QNRX$5.57COMPARE
PMCB$0.53COMPARE
TCRT$1.76COMPARE
RADX$2.44COMPARE